http://www.ed.ac.uk/

Cochrane entities >

Cochrane Peripheral Vascular Diseases Group

Our reviews

The scope of the Peripheral Vascular Diseases Group is broad and includes prevention, treatment and rehabilitation for all diseases of the arteries and veins. Some of our reviews compare medical and surgical treatments and may be listed more than once. As the scope of the Group is broad, there are areas of overlap with other groups. Predominantly evidence from randomised controlled trials and controlled clinical trials is used for reviewing health care interventions. Please note that this is not a definitive list; the Group should be contacted with any queries regarding the scope. There are obvious gaps in our title coverage.

If you think you could help us and you would like to register a title, please contact Heather Maxwell (h.g.maxwell@ed.ac.uk), or fill in a title registration form.

Title registration form (pdf)
Instructions for filling in a title registration form (pdf)
Title registration form (word doc)
Instructions for filling in a title registration form (word doc)

Update a review

It is Collaboration policy that all reviews must be updated at least every two years, even if this is simply to state that no new trials have been found since the last publication. On registering a title with the Peripheral Vascular Diseases Group, review authors are made aware that their reviews must be updated regularly. To assist with this, we will perform further literature searches approximately 12 and 20 months after publication, or sooner if the results from ongoing studies become available. We will notify you of any potentially relevant trials from which data may be extracted and incorporated into the review.
Contact Karen Welch for updating information (karen.welch@ed.ac.uk)

 

Can't find a review topic below covering your question or interest? Suggest one:
*
 

Full list:

By subtopic:

Peripheral Vascular Diseases Group (323)
Aortic aneurysm, abdominal and peripheral aneurysm (16)
Prevention (0)
Treatment (16)
Medical/conservative treatments (3)
Beta-blockers (0)
Haemodilution (0)
Observation (1)
Surgery for small asymptomatic abdominal aortic aneurysms
Screening (1)
Screening for abdominal aortic aneurysm
Thrombin injection (1)
Treatment for femoral pseudoaneurysms
Physical (1)
Ultrasound guided compression (1)
Treatment for femoral pseudoaneurysms
Surgical treatments (pre-, peri- or post-operatively) (12)
Alpha-agonists (0)
Anticoagulants (0)
ACE inhibitors (0)
Anaesthesia - techniques used (1)
General versus loco-regional anaesthesia for endovascular aneurysm repair (protocol stage)
Analgesics (0)
Antibiotics (1)
Prevention of infection in arterial reconstruction
Antiplatelets (0)
Beta-agonists (0)
Beta-blockers (0)
Blood transfusion (0)
Calcium antagonists (0)
Care (medical) during surgery (1)
Prevention of infection in arterial reconstruction
Catecholamines (0)
Cell saver - use of (0)
Cytoprotectants (0)
Cerebrospinal fluid drainage (1)
Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery
Cytochromes (factors affecting cytochrome system) (0)
Fluids (1)
Intravenous fluids for abdominal aortic surgery
Graft types (1)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
H2 blockers (0)
Haemodilution (0)
Heparin agonists (0)
Hydration - optimal pre-operative (0)
Incision - types of (0)
IV nutrition (0)
Lumbar sympathectomy (0)
Optiate antagonists (0)
Prostaglandins (0)
Pre-operative factors (not drugs or hydration) (0)
Sedatives (0)
Surgical techniques (3)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
Endovascular treatment for ruptured abdominal aortic aneurysm
Treatment for femoral pseudoaneurysms
Surgery versus non-surgical treatment (3)
Endovascular repair of abdominal aortic aneurysm (protocol stage)
Surgery for small asymptomatic abdominal aortic aneurysms
Treatment for femoral pseudoaneurysms
Temperature (0)
Thromboxane antagonists (0)
Vasodilators (0)
Rehabilitation (0)
Acute limb ischaemia (5)
Prevention (0)
Treatment (5)
Medical treatments (1)
Anticoagulants (0)
Antibiotics (0)
Fibrinolytics (0)
Rheological agents (0)
Thrombolysis (1)
Surgery versus thrombolysis for initial management of acute limb ischaemia
Surgical treatments (4)
Amputations (2)
Criteria for determining level of amputation (0)
Flaps used in amputation (1)
Type of incision for below knee amputation
Surgical techniques (1)
Type of incision for below knee amputation
Treatments given pre-, peri- or post-operatively (including following list to 'Vasodilators') (0)
Analgesics (0)
Anaesthetics (0)
Antibiotics (0)
Antipsychotics (0)
Antiplatelets (0)
Compression dressings (0)
Dressings (0)
Electromyostimulation (0)
Fibrinolytics (0)
Prostaglandins (0)
Phototherapy (0)
Vasodilators (0)
Anaesthetics used during surgery (0)
Drugs used pre-, peri- or post-operatively (1)
Beta-blockers (1)
Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)
Surgical revascularisation (0)
Surgical thrombectomy (1)
Surgery versus thrombolysis for initial management of acute limb ischaemia
Drugs used during surgical thrombectomy (0)
Rehabilitation (0)
Prostheses (0)
Rehabilitation methods (0)
Amputation (2)
Prevention (0)
Treatment (1)
Flaps used in amputation (1)
Type of incision for below knee amputation
Rehabilitation (1)
Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation
Aortic Dissection (1)
Endovascular versus conventional treatment for type B aortic dissection (protocol stage)
Aortic aneurysm, thoracic (3)
Treatment (3)
Cerebrospinal fluid drainage (1)
Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery
Surgical (2)
Thoracic stent graft versus surgery for thoracic aneurysm
Thoracic stent graft versus surgery for traumatic thoracic transection (protocol stage)
Critical limb ischaemia (45)
Prevention (0)
Treatment (45)
Lifestyle treatments (3)
Diet (1)
Lipid-lowering for peripheral arterial disease of the lower limb
Exercise (1)
Bypass surgery for chronic lower limb ischaemia
Lipid lowering (1)
Lipid-lowering for peripheral arterial disease of the lower limb
Medical treatments (5)
Amino acids (0)
Anticoagulants (0)
Analgesics (0)
Antibiotics (0)
Antiplatelets (1)
Sarpogrelate for peripheral arterial disease (protocol stage)
Buflomedil (0)
Dextran (0)
Haemodialysate (0)
Energy rich phosphates (0)
Fibrinolytics (0)
Gene therapy (0)
Herbal preparations (0)
Lipid lowering (1)
Lipid-lowering for peripheral arterial disease of the lower limb
Metabolic activators (0)
Methyl xanthines (0)
Naftidrofuryl (1)
Intravenous naftidrofuryl for critical limb ischaemia
Prostaglandins (1)
Prostanoids for critical limb ischemia (protocol stage)
Pentoxifylline (0)
Rutosides (0)
Serotonin antagonists (0)
Stem cell transplantation (0)
Thrombolytics (1)
Bypass surgery for chronic lower limb ischaemia
Thromboxane antagonists (0)
Vasodilators (0)
Vasospastic agents (0)
Surgical treatment (37)
Amputation (see 'Acute limb ischaemia' for details) (0)
Angioplasty (24)
Treatments/interventions during angioplasty (including following list to 'Prostaglandins') (3)
Angioplasty versus stenting for superficial femoral artery lesions
Cryoplasty for peripheral vascular disease
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Antibiotics (0)
Antiplatelets (0)
Buflomedil (0)
Haemostatic devices (0)
Oxygen supplementation (0)
Pre-operative drugs (0)
Prostaglandins (0)
Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Cryoplasty for peripheral vascular disease
Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)
Balloon dilatation (5)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Cryoplasty for peripheral vascular disease
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)
Cryoplasty (1)
Cryoplasty for peripheral vascular disease
Closure techniques (0)
Laser recanalisation (1)
Atherectomy for peripheral arterial disease (protocol stage)
Guide wires (0)
Angipolasty versus other surgical techniques (4)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery for chronic lower limb ischaemia
Endovascular stents for intermittent claudication
Angioplasty versus non-surgical treatments (1)
Angioplasty (versus non surgical management) for intermittent claudication
Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (0)
Anticoagulants (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Anaesthetics (0)
Antiplatelets (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Brachytherapy (1)
Intravascular brachytherapy for peripheral vascular disease
Dextran (0)
Essential fatty acids (0)
Haemodilution (0)
Lipid lowering (0)
Other treatments/interventions (1)
Endovascular stents for intermittent claudication
Prostaglandins (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Atherectomy (including endarterectomy and thromboendarterectomy) (2)
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery for chronic lower limb ischaemia
Bypass surgery (2)
Bypass surgery for chronic lower limb ischaemia
Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)
Drugs used pre-, peri- or post-operatively (1)
Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)
Spinal cord stimulation (2)
Bypass surgery for chronic lower limb ischaemia
Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia
Stent insertion (4)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)
Surgical technique (1)
Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)
Sympathectomy (1)
Sympathectomy for peripheral arterial disease (protocol stage)
Rehabilitation (0)
Chronic venous insufficiency (9)
Prevention (3)
Compression (1)
Prevention of venous insufficiency in a standing workers population (protocol stage)
Exercise (1)
Prevention of venous insufficiency in a standing workers population (protocol stage)
Work place intereventions (1)
Prevention of venous insufficiency in a standing workers population (protocol stage)
Treatment (6)
Lifestyle treatments (0)
Exercise (0)
Education (0)
Counselling (0)
Medical treatments (5)
Anticoagulants (0)
Calcium antagonists (0)
Fibrinolytics (0)
Flavonoids (1)
Phlebotonics for venous insufficiency
Herbal preparations (2)
Horse chestnut seed extract for chronic venous insufficiency
Phlebotonics for venous insufficiency
Non-steroidal anti-inflammatories (0)
Rheological agents (0)
Ruscus extracts (0)
Rutosides (1)
Phlebotonics for venous insufficiency
Steroids (0)
Thrombolytics (0)
Topical treatments (0)
Venoactive agents (1)
Phlebotonics for venous insufficiency
Physical treatments (0)
Compression treatments (0)
Leg elevation (0)
Surgical treatments (1)
Surgery for deep venous incompetence
Rehabilitation (0)
Heparin_induced thrombocytopenia (HIT) (1)
Prevention (1)
Medical prophylaxis (1)
Anticoagulants (1)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)
Oedema (0)
Prevention (0)
Treatment (0)
Medical treatments (0)
Bradykinin antagonists (0)
Diuretics (0)
Herbal preparations (0)
Rutosides (0)
Saccharides (0)
Steroids (0)
Venoactive agents (0)
Physical treatments (0)
Compression (0)
Elevation of legs (0)
Rehablitation (0)
Peripheral arterial occlusive disease (PAOD) (80)
Prevention (0)
Treatment (80)
Lifestyle treatments (7)
Diet (2)
Lipid-lowering for peripheral arterial disease of the lower limb
Omega-3 fatty acids for intermittent claudication
Exercise (3)
Bypass surgery for chronic lower limb ischaemia
Exercise for intermittent claudication
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
Lipid lowering (2)
Lipid-lowering for peripheral arterial disease of the lower limb
Omega-3 fatty acids for intermittent claudication
Medical treatments (28)
Amino acids (0)
Alpha blockers (0)
Angiogenesis (0)
Anticoagulants (2)
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
ACE inhibitors (0)
Alcohol (0)
Antioxidants (1)
Vitamin E for intermittent claudication
Antiplatelets (4)
Antiplatelet agents for intermittent claudication (protocol stage)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Cilostazol for peripheral arterial disease
Sarpogrelate for peripheral arterial disease (protocol stage)
Bamethane sulphate (0)
Bradykin antagonists (0)
Beta-blockers (2)
Beta blockers for peripheral arterial disease
Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)
Biguanides (0)
Blood pressure lowering drugs (0)
Buflomedil (1)
Buflomedil for intermittent claudication
Calcium antagonists (0)
Calcitonin (0)
Cerebral activator agents (0)
Chelation therapy (1)
Chelation therapy for atherosclerotic cardiovascular disease
Chemical sympathectomy (0)
Carbon dioxide (0)
Co-enzymes for vitamins (0)
Cytochromics (0)
Depropanox (0)
Dextran (0)
Essential fatty acids (1)
Omega-3 fatty acids for intermittent claudication
Energy rich phosphates (0)
Fibrinolytics (2)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Fibrinolytic agents for peripheral arterial occlusion (protocol stage)
Gene therapy (1)
Gene therapy for peripheral arterial disease (protocol stage)
Glucose metabolites (0)
Haemodialysate (0)
Haemodilution (0)
Herbal preparations (3)
Garlic for peripheral arterial occlusive disease
Ginkgo biloba for intermittent claudication
Padma 28 for intermittent claudication (protocol stage)
Homocysteine-lowering interventions (1)
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
Hypoglycaemic agents (oral) (0)
Ifenprodil (0)
Lipid lowering (2)
Lipid-lowering for peripheral arterial disease of the lower limb
Omega-3 fatty acids for intermittent claudication
Monoamine oxidase inhibitors (0)
Methyl blue (0)
Methyldopa (0)
Methyl xanthine (0)
Narcain antagonists (0)
Nerve block (0)
Naftidrofuryl (1)
Naftidrofuryl for intermittent claudication
Neuroleptics (0)
Oestrogens (0)
Oxygen supplementation (0)
Ozone treatment (0)
Pantetheine (0)
Prostaglandins (2)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Prostanoids for intermittent claudication
Pentoxifylline (2)
Cilostazol for peripheral arterial disease
Pentoxifylline for intermittent claudication (protocol stage)
Rheological agents (0)
Rutosides (0)
Serotonin antagonists (0)
Suphonylurea (0)
Testosterone (1)
Steroid sex hormones for lower limb atherosclerosis
Thrombolytics (1)
Bypass surgery for chronic lower limb ischaemia
Topical treatments (0)
Trace elements (0)
Thromboxane antagonists (0)
Vasodilators (0)
Vasospastic agents (0)
Physical treatments (0)
Electromagnetic field (diapulse) (0)
Electromyostimulation (0)
Immersion therapy (0)
Massage treatment (0)
Intermittent suction pressure treatment (0)
Surgical treatments (41)
Amputation (see 'Acute limb ischaemia' for details) (1)
Type of incision for below knee amputation
Angioplasty (see 'Critical limb ischaemia' for details) (21)
Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Cryoplasty for peripheral vascular disease
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Balloon dilatation (6)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction
Cryoplasty for peripheral vascular disease
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)
Cryoplasty (1)
Cryoplasty for peripheral vascular disease
Angioplasty versus other surgical techniques (5)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery for chronic lower limb ischaemia
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Endovascular stents for intermittent claudication
Angioplasty versus non-surgical treatments (1)
Angioplasty (versus non surgical management) for intermittent claudication
Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (1)
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Anticoagulants (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Antiplatelets (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Proastaglandins (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Atherectomy (including endarterectomy and thromboendarterectomy) (2)
Atherectomy for peripheral arterial disease (protocol stage)
Bypass surgery for chronic lower limb ischaemia
Brachytherapy (1)
Intravascular brachytherapy for peripheral vascular disease
Bypass surgery (10)
Medical treatments/interventions pre-, peri- or post-operatively (including following list to 'Venoactive agents') (1)
Prevention of infection in arterial reconstruction
Anticoagulants (1)
Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
ACE inhibitors (0)
Anaesthesia (0)
Analgesics (0)
Antibiotics (1)
Prevention of infection in arterial reconstruction
Antioxidants (0)
Antiplatelets (1)
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery
Calcium antagonists (0)
Cholinergic agents (0)
Dextran (0)
Homocysteine-lowering interventions (1)
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
Intensive surveillance (0)
IV fluids (0)
Lipid lowering drugs (0)
Medical care during surgery (1)
Prevention of infection in arterial reconstruction
Pentoxifylline (0)
Post-operative management (drains etc) (1)
Prevention of infection in arterial reconstruction
Pre-operative hydration (0)
Pre-operative drugs (0)
Pre-operative factors (not drugs or hydration) (0)
Prostaglandins (0)
Temperature (0)
Thrombolysis (1)
Bypass surgery for chronic lower limb ischaemia
Thromboxane antagonists (0)
Xanthine oxidase inhibitors (0)
Venoactive agents (0)
Surgical interventions (including following list to 'Types of sutures') (1)
Bypass surgery for chronic lower limb ischaemia
Atherectomy of occluded bypass (0)
Thrombolysis with catheter (0)
Graft types (1)
Graft type for femoro-popliteal bypass surgery
Types of incision (0)
Lumbar sympathectomy (0)
Surgical techniques (0)
Types of sutures (0)
Spinal cord stimulation (1)
Bypass surgery for chronic lower limb ischaemia
Stent insertion (4)
Angioplasty versus stenting for superficial femoral artery lesions
Atherectomy for peripheral arterial disease (protocol stage)
Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)
Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)
Thrombolysis with catheter (1)
Infusion techniques for peripheral arterial thrombolysis
Lumbar sympathectomy (0)
Venesection (0)
Treatment of complications associated with PAOD (4)
Prevention of restenosis/re-occlusion after treatment (4)
Anticoagulants (1)
Angioplasty (versus non surgical management) for intermittent claudication
Antiplatelets (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Fibrinolytics (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Prostaglandins (1)
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
Medical treatments (0)
Anticoagulants (0)
Antiplatelets (0)
Beta-blockers (0)
Blood pressure lowering drugs (0)
Calcium antagonists (0)
Serotonin antagonists (0)
Surgical treatments (0)
Lumbar sympathectomy (0)
Rehabilitation (0)
Thromboembolism (117)
Deep vein thrombosis (DVT) related (59)
Diagnostic Test Accuracy (0)
Prevention (41)
Medical prophylaxis (24)
Anticoagulants (12)
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (protocol stage)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)
Antioxidants (0)
Antithrombotics (4)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Antiplatelets (1)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Biguanides (0)
Calcium antagonists (0)
Chloroquine and derivatives (0)
Cyctotoxic/DNA reactive drugs (0)
Dextran (0)
Direct Thrombin Inhibitors (1)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Fibrinolytics (0)
Immunosuppressants (0)
Indirect Thrombin Inhibitors (1)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Method of administration (1)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Non-steroidal anti-inflammatories (0)
Oestrogens (0)
Pentasaccharides (3)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Polysaccharides (0)
Protease inhibitors (0)
Pentoxifylline (0)
Rheological agents (0)
Statins (0)
Steroid hormones (0)
Testosterone/anabolic steroids (0)
Vasodilators (0)
Vitamin K Antagonists (1)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Surgical prophylaxis (0)
Anaesthetic (0)
Cement (orthopaedic surgery) (0)
Catheter material (0)
Catheter location (0)
IV fluids (0)
Risk assessment (0)
Tourniquet (0)
Physical methods of prophylaxis (17)
Compression (stockings) (8)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Compression stockings for preventing deep vein thrombosis in airline passengers
Elastic compression stockings for prevention of deep vein thrombosis
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis (protocol stage)
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Elevation of bed/feet (1)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Electromyostimulation (1)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Exercise (1)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Mechanical prophylaxis (5)
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Mobilisation (1)
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)
Other methods of prophylaxis (0)
Risk assessment (0)
Treatment (18)
Medical treatment (18)
Anticoagulant monitoring (1)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Anticoagulants (11)
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
Home versus in-patient treatment for deep vein thrombosis
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Thrombolysis for acute deep vein thrombosis
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Antiplatelets (0)
Biguanides (0)
Fibrinolytics (1)
Thrombolysis for acute deep vein thrombosis
Location of treatment (1)
Home versus in-patient treatment for deep vein thrombosis
Method of administration (2)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Non-steroidal anti-inflammatories (1)
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Pentasaccharides (0)
Polysaccharides (0)
Proteolytic enzymes (0)
Rheological agents (0)
Thrombolytics (1)
Thrombolysis for acute deep vein thrombosis
Surgical treatment (0)
Angioplasty (0)
Arterio-venous fistulae (0)
Filter insertion (0)
Surgical removal (0)
Thrombectomy (0)
Physical treatment (0)
Compression (0)
Mechanical treatment (0)
Idiopathic recurrent vein thrombosis (0)
Prevention (0)
Medical prophylaxis (0)
Anticoagulants (0)
Antiplatelets (0)
Biguanides (0)
Physical prophylaxis (0)
Compression (0)
Treatment (0)
Antiplatelets (0)
Not DVT related (6)
Prevention (5)
Anticoagulants (3)
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Method of administration (1)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Non-steroidal anti-inflammatories (0)
Physical prevention methods (1)
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Treatment (1)
Anticoagulants (0)
Method of administration (1)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Non-steroidal anti-inflammatories (0)
Rehabilitation (0)
Post thrombotic syndrome (PTS) (7)
Prevention (4)
Medical prophylaxis (1)
Rutosides (1)
Rutosides for prevention of post thrombotic syndrome (protocol stage)
Physical methods of prophylaxis (3)
Compression (stockings) (1)
Non-pharmaceutical measures for prevention of post-thrombotic syndrome
Elevation of bed/feet (1)
Non-pharmaceutical measures for prevention of post-thrombotic syndrome
Mechanical prophylaxis (1)
Non-pharmaceutical measures for prevention of post-thrombotic syndrome
Treatment (3)
Compression (stockings) (1)
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome
Mechanical treatment (1)
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome
Medical (1)
Rutosides (1)
Rutosides for treatment of post-thrombotic syndrome (protocol stage)
Pulmonary Embolism (PE) (45)
Prevention (35)
Medical prophylaxis (26)
Anticoagulants (11)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (protocol stage)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)
Vena caval filters for the prevention of pulmonary embolism
Antiplatelet agents (1)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Antithrombotics (6)
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Vena caval filters for the prevention of pulmonary embolism
Direct Thrombin Inhibitors (1)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Indirect Thrombin Inhibitors (1)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Method of administration (1)
Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)
Pentasaccharides (3)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Statins (0)
Vitamin K antagonists (2)
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)
Vena caval filters for the prevention of pulmonary embolism
Physical methods of prophylaxis (8)
Compression (stockings) (4)
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Mechanical prophylaxis (4)
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Pentasaccharides for the prevention of venous thromboembolism (protocol stage)
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)
Surgical intervention (1)
Filter insertion (1)
Vena caval filters for the prevention of pulmonary embolism
Treatment (10)
Medical treatment (9)
Anticoagulant monitoring (1)
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Anticoagulants (4)
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Thrombolytic therapy for pulmonary embolism
Warfarin initiation nomograms for venous thromboembolism (protocol stage)
Fibrinolytics (1)
Thrombolytic therapy for pulmonary embolism
Method of administration (1)
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Non-steroidal anti-inflammatories (1)
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism
Pentasaccharides (0)
Thrombolytics (1)
Thrombolytic therapy for pulmonary embolism
Surgical treatment (1)
Thrombolytic therapy for pulmonary embolism
Physical treatment (0)
Thrombophilia (1)
Treatment (1)
Thrombophilia testing for prevention of recurrent venous thromboembolism
Thrombophlebitis (12)
Cannulation phlebitis (4)
Prevention (4)
Medical prevention methods (2)
Anticoagulants (2)
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)
Analgesics (0)
Anti-inflammatories (0)
IV fluids (0)
Steroids (0)
Physical prevention methods (2)
Cannula - size of bore, length, material etc (1)
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Duration of cannulisation (0)
Equipment - set up, and delivery systems (0)
Location of cannula (0)
Optimum replacement indications (1)
Clinically indicated replacement versus routine replacement of peripheral venous catheters (protocol stage)
Treatment (0)
Medical treatments (0)
Anticoagulants (0)
Antiplatelets (0)
Biguanides (0)
Fibrinolytics (0)
Non-steroidal anti-inflammatories (0)
Rheological agents (0)
Rutosides (0)
Sedatives (0)
Serotonin antagonists (0)
Steroids (0)
Superficial thrombophlebitis (8)
Prevention (0)
Treatment (8)
Medical treatments (3)
Anticoagulants (1)
Treatment for superficial thrombophlebitis of the leg
Non steroidal anti-inflammatories (1)
Treatment for superficial thrombophlebitis of the leg
Topical (1)
Treatment for superficial thrombophlebitis of the leg
Physical (2)
Compression (1)
Treatment for superficial thrombophlebitis of the leg
Elevation (1)
Treatment for superficial thrombophlebitis of the leg
Surgical treatments (3)
Crossectomy (1)
Treatment for superficial thrombophlebitis of the leg
Ligation (1)
Treatment for superficial thrombophlebitis of the leg
Vein stripping (1)
Treatment for superficial thrombophlebitis of the leg
Ulcers (arterial and mixed) (2)
Prevention (0)
Treatment (2)
Medical treatments (2)
Anticoagulants (0)
Antibiotics (0)
Antiplatelets (0)
Bradykinin antagonists (0)
Calcium antagonists (0)
Cell suspensions (0)
Co-enzymes for vitamin function (0)
Dressings (1)
Dressings and topical agents for arterial leg ulcers
Energy rich phosphates (0)
Fibrinolytics (0)
Growth hormones (0)
Herbal preparations (0)
Levamisole (0)
Metabolic activators (0)
Naftidrofuryl (0)
Oygen supplementation (0)
Prostaglandins (0)
Polysaccharides (0)
Proteolytic enzymes (0)
Pentoxifylline (0)
Rheological agents (0)
Ruscus extracts (0)
Topical treatments (1)
Dressings and topical agents for arterial leg ulcers
Trace elements (0)
Vasodilators (0)
Venoactive agents (0)
Physical treatments (0)
Compression (eg Una's boot) (0)
Electromagnetic field therapy (0)
Electromyostimulation (0)
Phototherapy (0)
Spinal cord stimulation (0)
Ultrasound (0)
Surgical treatments (0)
Laser treatment (0)
Skin grafts (0)
Surgery (0)
Rehabilitation (0)
Vasculitis (10)
Kawasaki disease (7)
Treatment (7)
Immunoglobulin (3)
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Salicylate for the treatment of Kawasaki disease in children
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Salicylate (3)
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Salicylate for the treatment of Kawasaki disease in children
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Steroid (1)
Steroid hormone treatment for Kawasaki disease in children (protocol stage)
Wegener's granulomatosis (3)
Treatment (3)
Immunoglobulin (1)
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Immunosuppressants (1)
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Steroids (1)
Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Vasospastic disorders (Primary Raynaud's Phenomenon) (6)
Prevention (0)
Treatment (6)
Medical treatments (6)
Amino acids (0)
Alpha-agonists (0)
Alpha-blockers (0)
ACE inhibitors (1)
Oral vasodilators for primary Raynaud's phenomenon
Adrenergic blockers (0)
Antiplatelets (0)
Beta-antagonists (0)
Beta-blockers (0)
Bradykin antagonists (0)
Buflomedil (0)
Calcium antagonists (1)
Calcium channel blockers for primary Raynaud's Phenomenon (protocol stage)
Dextran (0)
Essential fatty acids (0)
Naftidrofuryl (0)
Platelet aggregation inhibitors (1)
Oral vasodilators for primary Raynaud's phenomenon
Prostaglandins (0)
Pentoxifylline (0)
Rheological agents (0)
Serotonin antagonists (1)
Oral vasodilators for primary Raynaud's phenomenon
Thyroid hormone (0)
Topical applications (0)
Thromboxane antagonists (1)
Oral vasodilators for primary Raynaud's phenomenon
Vasodilators (1)
Oral vasodilators for primary Raynaud's phenomenon
Vasospastic agents (0)
Physical treatments (0)
Autogenic training (relaxation etc) (0)
Electromyelogram (0)
Temperature biofeedback (0)
Rehabilitation (0)
Varicose veins (10)
Prevention (0)
Treatment (10)
Medical treatments (0)
Analgesics (0)
Antibiotics (0)
Antiplatelets (0)
Calcium antagonists (0)
Energy rich phosphates (0)
Glucose (0)
Homeopathic remedies (0)
Ruscus extract (0)
Rutosides (0)
Topical treatments (0)
Venoactive agents (0)
Vasodilators (0)
Vasospastic agents (0)
Physical treatments (0)
Compression (0)
Exercise (0)
Stockings (0)
Surgical treatments (10)
Endovenous ablation (1)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices (protocol stage)
Closure techniques (0)
Foam sclerotherapy (1)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices (protocol stage)
Laser endovenous ablation (1)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices (protocol stage)
Post-sclerotherapy treatments (1)
Compression (1)
Injection sclerotherapy for varicose veins
Post-surgical treatments (1)
Compression (1)
Injection sclerotherapy for varicose veins
Radiofrequency endovenous ablation (1)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices (protocol stage)
Sclerotherapy (1)
Surgery versus sclerotherapy for the treatment of varicose veins
Surgery (3)
Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus conventional surgery for long saphenous vein varices (protocol stage)
Surgery for varicose veins: use of tourniquet
Surgery versus sclerotherapy for the treatment of varicose veins
Rehablitation (0)
Other peripheral vascular problems including (3)
Arterio-venous fistulae (2)
Autologous versus prosthetic arteriovenous fistulae for vascular access (protocol stage)
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
Chilblains (0)
Capillary fragility (0)
Hypertension (mainly responsibility of Cochrane Hypertension Group) (1)
Treatment of hypertension in peripheral arterial disease
Polyarteritis nodosa (0)
Healthy volunteers testing (0)
Medical treatments (0)
Amino acids (0)
Anticoagulants (0)
ACE inhibitors (0)
Alcohol (0)
Anaesthetics (0)
Antibiotics (0)
Antioxidants (0)
Antiplatelets (0)
 
.

Search 

Tips

Advanced

 

top of this page contact disclaimer The Cochrane Library The Cochrane Collaboration